Biotech & Medtech
Biotech & Medtech news — Tuesday 17 November 2026
26 stories from 4 sources, every one in English. Each links to its publisher.
-
Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platform
Health systems are jumping to integrate AI into clinicians’ everyday tools. When those platforms also offer the medical evidence that healthcare providers need to make on-the-fly clinical decisions, patient care can improve. Viz.ai and…
-
Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs
Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both blood disorders, Marrow executives say manufacturing and dosing advantages could make their medicine more broadly…
-
STAT+: Updated health data privacy rule sets standards for sharing records with apps
On Monday, the Department of Health and Human Services issued a long-awaited update to the Health Insurance Portability and Accountability Act privacy rule. Originally proposed in January 2021, HHS’ Office for Civil Rights finalized…
-
STAT+: GOP, MAHA leaders clash over FDA nominee’s record on vapes
WASHINGTON — The fight over Heidi Overton’s nomination for Food and Drug Commissioner is surfacing divides within the GOP over health policy and threatening to tank the party’s chances of confirming an FDA leader during the lame duck…
-
STAT+: What to know about the new AI roadmap from CMS, and news from HLTH
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! Hello…
-
Roche breast cancer pill cleared by FDA
Wilserdly’s U.S. approval is seen by analysts as a “key first step” in an important launch for Roche, which has claimed the drug could become its top-selling product.
-
STAT+: Flagship opens biotech-creation outpost in the U.K.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got a lot of news to get into today, including some big developments in oncology. The…
-
U.S. loses measles elimination status, marking embarrassing stain on its public health record
International health officials said Tuesday that measles is no longer considered eliminated in the United States, a finding that was widely expected but that marks an embarrassing and avoidable backslide in the country’s basic public…
-
AI drugmaker Isomorphic restocks with $5B fundraise
Even as the larger AI industry faces turmoil, investors have given Isomorphic the two largest cash infusions in the biotech sector this year.
-
STAT+: ‘Medicare for More’ gains traction
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The teddy bear added a cuddly…
-
Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Does
If health systems want to adopt AI at scale, they need evaluation that is open, reproducible, and continuously updated. That’s also much harder to build in healthcare than in general-purpose AI, for these 3 reasons. The post Your AI…
-
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily…
-
The BCI Race Everyone is Watching May Be the Wrong One
The technology race gets the attention. Another race may determine what becomes the new standard of care. The post The BCI Race Everyone is Watching May Be the Wrong One appeared first on MedCity News .
-
Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Next
Payment isn’t the only barrier, but it shapes all the others. The post Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Next appeared first on MedCity News .
-
NIH’s infectious disease unit has a new head at last
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning and happy Tuesday! Today’s newsletter includes good news for international students, bad news for the makers…
-
Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conference
[Sponsored] MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups seeking to address painpoints in healthcare, from digital twin technology to support oncology drug…
-
STAT+: With $173 million, new startup takes aim at sickle cell
For years, researchers and investors have been searching for a treatment that’s as effective in treating sickle cell disease as gene therapy — but without the many drawbacks . Biotech entrepreneur Romesh Subramanian thinks he might have…
-
STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial
It looks like I was wrong about Sellas Life Sciences and its experimental blood cancer immunotherapy. On Tuesday, Sellas said the therapy, called galinpepimut-S, reduced the risk of death by 41% compared to standard treatment for patients…
-
Marrow sets out to challenge genetic medicines for severe blood diseases
Armed with $173 million in venture funding, the startup is developing what it’s positioning as a more accessible alternative to gene therapy and gene editing treatments for sickle cell and beta thalassemia.
-
STAT+: After death in gene therapy trial for a brain disease, progress is reported
Researchers on Friday presented detailed investigations into a gene therapy death that sparked fear and uncertainty last year among scientists who felt they had been approaching powerful treatments for a long list of brain diseases. The…
-
Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates
This article was first reported by The Examination , a nonprofit newsroom that investigates global health threats. The latest product from the tobacco industry is a flavorful nicotine tablet that melts in your mouth, allowing users to get…
-
Opinion: The problem with ‘zero tolerance for bad behavior’ signs at hospitals
Enter any hospital today and you’ll see signs warning patients and visitors that abusive language, disruptive behavior, or aggression will not be tolerated. Some threaten removal from the facility. Others warn that security or police may…
-
Faith-based addiction recovery groups don’t often get federal funding. RFK Jr. wants to change that
While campaigning the week before the midterms, health secretary Robert F. Kennedy Jr. visited Sheepgate, a Christian addiction recovery center in Colfax, Iowa. Sheepgate, Kennedy said, is a model for the type of faith-based center that…
-
Doc at HLTH: I Can’t Imagine Seeing Patients Without AI
A part-time urgent care doctor who runs healthcare and life sciences projects at Anthropic as well as other AI experts discussed how AI can boost primary care. The post Doc at HLTH: I Can’t Imagine Seeing Patients Without AI appeared first…
-
Noom Introduces Wearable to Support Obesity Care Programs
Noom is launching a wearable in 2027 to support weight management and metabolic health through health tracking and personalized coaching. The post Noom Introduces Wearable to Support Obesity Care Programs appeared first on MedCity News .
-
Author Correction: The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
Nature Biotechnology, Published online: 17 November 2026; doi:10.1038/s41587-026-03405-9 Author Correction: The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications